Linde Short Interest Jumps 24.9% to 8.44M Shares, Analysts Cut Targets
Short interest in Linde climbed 24.9% to 8.44M shares as of Dec 15, equating to 1.8% of float and a 2.5-day covering ratio. Analysts have lowered price targets to $455–$520 (consensus $501) after Q3 EPS of $4.21 topped estimates by $0.03 and dividend yield stands at 1.4%.
1. Weekly Adhishthana Cycle Signals Heightened Downside Risk
Linde’s weekly chart has entered Phase 9 of its 18-phase Adhishthana cycle, a juncture where traditional bullish structure should trigger a clean breakout. Instead, the stock violated its Cakra formation on October 6, initiating the bearish Move of Pralaya. Since that breakdown, shares have fallen by more than 15%, a pattern that historically precedes further weakness. The premature breakout attempts within Phases 4–8 undermined structural integrity, raising a red flag for latent vulnerabilities even as underlying fundamentals remain sound.
2. Monthly Framework Points to Potential Cycle Peak
On the monthly timeframe, Linde completed a textbook Cakra between Phases 4 and 8 and enjoyed a subsequent rally of over 193% into Phase 9. Phase 10, typically associated with peak formation in the Himalayan sequence, has shown early signs of exhaustion in recent sessions. The stock marked its all-time high squarely within this interval, suggesting that the ascent leg may have concluded. When combined with the weekly breakdown, the monthly setup tilts toward the descent phase, implying that investors should prepare for a structural top rather than another leg higher.
3. Short Interest Climbs Sharply in December
Short interest in Linde climbed to 8,441,173 shares as of December 15, up 24.9% from 6,758,131 shares at the end of November. With an average daily volume of 3,439,334 shares, the days-to-cover ratio stands at 2.5 days. Approximately 1.8% of the float is now sold short—a level that, when combined with the Adhishthana warnings, underscores growing bearish conviction among hedge funds and tactical traders.
4. Analyst Sentiment and Capital Allocation Considerations
Wall Street’s consensus remains a Buy based on 10 recent research reports: two Strong Buy, seven Buy and one Hold. Analysts have adjusted their EPS guidance for fiscal 2025 to a range of 16.35–16.45 and Q4 2025 to 4.10–4.20, reflecting modest upward revisions to expected profitability. Large institutional investors continue to hold over 82% of outstanding shares, with Norges Bank adding roughly $3.1 billion in the second quarter and Lazard committing $453 million in the third. Given the shift in technical risk profile, current shareholders may consider hedges or option collars, while new entrants could await clearer confirmation that Phase 10 has resolved before increasing exposure.